These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29291781)

  • 1. Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation.
    Andert A; Ulmer TF; Schöning W; Kroy D; Hein M; Alizai PH; Heidenhain C; Neumann U; Schmeding M
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):617-623. PubMed ID: 29291781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Transplantation and Donor Body Mass Index >30: Use or Refuse?
    Andert A; Becker N; Ulmer F; Schöning W; Hein M; Rimek A; Neumann U; Schmeding M
    Ann Transplant; 2016 Mar; 21():185-93. PubMed ID: 27029495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of livers with microvesicular fat safely expands the donor pool.
    Fishbein TM; Fiel MI; Emre S; Cubukcu O; Guy SR; Schwartz ME; Miller CM; Sheiner PA
    Transplantation; 1997 Jul; 64(2):248-51. PubMed ID: 9256182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Predictive Ability for Graft Loss and Mortality of Two Criteria for Early Allograft Dysfunction After Liver Transplantation.
    Brea-Gómez E; Villar-Quintana R; Plata-Illescas C; Zambudio-Carroll N; Lopez-Garrido MA; Nogueras-Lopez F; Muffak-Granero K; Becerra-Massare A; Villegas-Herrera MT; Segura Jiménez I; Muñoz Pérez N; Villar-Del-Moral JM
    Transplant Proc; 2018 Mar; 50(2):605-609. PubMed ID: 29579865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
    Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
    Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hepatic macrovesicular and microvesicular steatosis on the postoperative liver functions after right hepatectomy in living donors.
    Shin YH; Ko JS; Kim GS; Gwak MS; Sim WS; Lee AR; Yi HW; Joh JW
    Transplant Proc; 2012 Mar; 44(2):512-5. PubMed ID: 22410058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.
    Wong TC; Fung JY; Chok KS; Cheung TT; Chan AC; Sharr WW; Dai WC; Chan SC; Lo CM
    Liver Transpl; 2016 Feb; 22(2):226-36. PubMed ID: 26359934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
    de Graaf EL; Kench J; Dilworth P; Shackel NA; Strasser SI; Joseph D; Pleass H; Crawford M; McCaughan GW; Verran DJ
    J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
    Lee DD; Croome KP; Shalev JA; Musto KR; Sharma M; Keaveny AP; Taner CB
    Ann Hepatol; 2016; 15(1):53-60. PubMed ID: 26626641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
    Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pure microsteatosis on transplant outcomes after living donor liver transplantation: a matched case-control study.
    Han S; Ko JS; Kwon G; Park C; Lee S; Kim J; Kim G; Kwon CD; Gwak M; Ha S
    Liver Transpl; 2014 Apr; 20(4):473-82. PubMed ID: 24425681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients.
    Nicolau-Raducu R; Cohen AJ; Bokhari A; Bohorquez H; Bruce D; Carmody I; Bugeaud E; Seal J; Sonnier D; Nossaman B; Loss G
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28856732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.
    Bispo M; Marcelino P; Marques HP; Martins A; Perdigoto R; Aguiar MJ; Mourão L; Barroso E
    Liver Transpl; 2011 Mar; 17(3):270-8. PubMed ID: 21384509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.
    Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J
    Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction.
    Verhelst X; Geerts A; Jochmans I; Vanderschaeghe D; Paradissis A; Vanlander A; Berrevoet F; Dahlqvist G; Nevens F; Pirenne J; Rogiers X; Callewaert N; Troisi RI; Van Vlierberghe H
    Gastroenterology; 2018 Apr; 154(5):1361-1368. PubMed ID: 29309776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.
    Salvalaggio PR; Felga GE; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2449-51. PubMed ID: 23026617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the postoperative cholesterol in early allograft dysfunction and survival after living donor liver transplantation.
    Yang J; Wang HQ; Yang JY; Wen TF; Li B; Wang WT; Yan LN
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):610-616. PubMed ID: 29291780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.